Candel Therapeutics, Inc. - Common stock, par value $0.0001 per share (CADL)

Historical Holders from Q3 2021 to Q3 2025

Symbol
CADL on Nasdaq
CUSIP
137404109
Type / Class
Equity / Common stock, par value $0.0001 per share
Shares outstanding
49.6M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
22.7M
Holdings value
$116M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
80
Number of buys
40
Number of sells
-36
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Candel Therapeutics, Inc. - Common stock, par value $0.0001 per share (CADL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +63.3% $30.1M $11.4M 6.32M +61% FMR LLC Jan 31, 2025
ACORN BIOVENTURES, L.P. 5.2% $12.4M 2.58M Anders Hove Jun 25, 2025
BAKER BROS. ADVISORS LP 4.99% -25.9% $11.7M -$2.51M 2.46M -17.7% Baker Bros. Advisors LP Mar 31, 2025

Institutional Holders of Candel Therapeutics, Inc. - Common stock, par value $0.0001 per share (CADL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 22.7M $116M -$1.87M $5.10 80
2025 Q2 23M $117M +$8.83M $5.06 78
2025 Q1 21.2M $120M +$12.5M $5.65 82
2024 Q4 17.9M $156M +$97.2M $8.68 69
2024 Q3 6.69M $46.4M +$3.07M $6.93 51
2024 Q2 5.96M $37M +$14M $6.20 47
2024 Q1 3.78M $5.97M -$232K $1.58 18
2023 Q4 4.03M $5.92M -$1.2M $1.47 20
2023 Q3 5.26M $4.86M -$148K $0.92 19
2023 Q2 5.37M $6.77M -$143K $1.26 19
2023 Q1 5.48M $7.44M +$69.5K $1.35 20
2022 Q4 5.42M $9.7M -$1.79M $1.79 20
2022 Q3 6.08M $19.1M -$834K $3.14 22
2022 Q2 6.35M $20.6M -$1.16M $3.24 19
2022 Q1 6.67M $34M -$1.72M $5.08 21
2021 Q4 6.95M $54.4M +$887K $7.82 20
2021 Q3 4.88M $52.9M +$44.1M $10.84 12